SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001520138-14-000254
Filing Date
2014-09-24
Accepted
2014-09-24 14:10:00
Documents
14
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nnab-20140630_10k.htm 10-K 441628
2 EXHIBIT 14.1 nnab-20140630_10kex14z1.htm EX-14.1 30507
3 EXHIBIT 31.1 nnab-20140630_10kex31z1.htm EX-31.1 12644
4 EXHIBIT 32.1 nnab-20140630_10kex32z1.htm EX-32.1 6202
5 GRAPHIC image_003.jpg GRAPHIC 19010
6 GRAPHIC image_004.jpg GRAPHIC 2535
7 GRAPHIC image_005.jpg GRAPHIC 6476
8 GRAPHIC image_006.jpg GRAPHIC 2788
  Complete submission text file 0001520138-14-000254.txt   1582952

Data Files

Seq Description Document Type Size
9 XBRL PRESENTATION FILE nnab-20140630_pre.xml EX-101.PRE 76984
10 XBRL INSTANCE FILE nnab-20140630.xml EX-101.INS 105106
11 XBRL SCHEMA FILE nnab-20140630.xsd EX-101.SCH 12905
12 XBRL CALCULATION FILE nnab-20140630_cal.xml EX-101.CAL 17303
13 XBRL DEFINITION FILE nnab-20140630_def.xml EX-101.DEF 22661
14 XBRL LABEL FILE nnab-20140630_lab.xml EX-101.LAB 98876
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 3055154118
NANOANTIBIOTICS, INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 333-190635 | Film No.: 141118168
SIC: 2834 Pharmaceutical Preparations